Cargando…
Drug discovery: Insights from the invertebrate Caenorhabditis elegans
Therapeutic drug development is a long, expensive, and complex process that usually takes 12–15 years. In the early phases of drug discovery, in particular, there is a growing need for animal models that ensure the reduction in both cost and time. Caenorhabditis elegans has been traditionally used t...
Autores principales: | Giunti, Sebastián, Andersen, Natalia, Rayes, Diego, De Rosa, María José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916527/ https://www.ncbi.nlm.nih.gov/pubmed/33641258 http://dx.doi.org/10.1002/prp2.721 |
Ejemplares similares
-
Caenorhabditis elegans: A Model System for Anti-Cancer Drug Discovery and Therapeutic Target Identification
por: Kobet, Robert A., et al.
Publicado: (2014) -
The invertebrate Caenorhabditis elegans biosynthesizes ascorbate
por: Patananan, Alexander N., et al.
Publicado: (2015) -
Exposome, Molecular Pathways and One Health: The Invertebrate Caenorhabditis elegans
por: von Mikecz, Anna
Publicado: (2022) -
In silico analysis of the binding of anthelmintics to Caenorhabditis elegansP-glycoprotein 1
por: David, Marion A., et al.
Publicado: (2016) -
The role of insulin/IGF-1 signaling in the longevity of model
invertebrates, C. elegans and D.
melanogaster
por: Altintas, Ozlem, et al.
Publicado: (2016)